3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Glioma
3
Glioblastoma
3
Astrocytoma
2
Whooping Cough
1
Sarcoma
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumococcal Infections
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Measles
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Hepatitis B
1
HIV Infections
1
Gliosarcoma
1
Carcinoma
1
Advanced Cancer
1
Interventions
Cyclophosphamide
110
fludarabine phosphate
106
Busulfan
84
Azacitidine
73
Peripheral Blood Stem Cell Transplantation
64
Mycophenolic Acid
64
Antilymphocyte Serum
64
Cytarabine
63
Tacrolimus
62
fludarabine
61
Cyclosporine
56
Filgrastim
55
Whole-Body Irradiation
52
Methotrexate
47
Melphalan
42
Decitabine
42
Radiotherapy
37
Clofarabine
29
Granulocyte Colony-Stimulating Factor
28
Cord Blood Stem Cell Transplantation
28
Methylprednisolone
24
Etoposide
24
thymoglobulin
21
Thiotepa
21
Stem Cell Transplantation
21
sargramostim
19
Sirolimus
16
Alemtuzumab
15
Lenalidomide
13
Gemtuzumab
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Myelodysplastic Syndromes
×
Tetanus Toxoid
×
Clear all
NCT01611298
2020-04-21
TAR
Baylor College of Medicine
Phase NA
Completed
7 enrolled
8 charts